AB
RXII

Amalgamated Bank’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Amalgamated Bank’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-19,454
Closed -$7K – 1530
2016
Q3 		$7K Buy
19,454
+106
+0.5% +$38 ﹤0.01% 1385
2016
Q2 		$8K Buy
19,348
+2,397
+14% +$991 ﹤0.01% 1380
2016
Q1 		$23K Buy
16,951
+1,403
+9% +$1.9K ﹤0.01% 1277
2015
Q4 		$23K Sell
15,548
-1,335
-8% -$1.98K ﹤0.01% 1191
2015
Q3 		$27K Buy
16,883
+152
+0.9% +$243 ﹤0.01% 1283
2015
Q2 		$28K Buy
16,731
+2,080
+14% +$3.48K ﹤0.01% 1352
2015
Q1 		$20K Buy
14,651
+3,127
+27% +$4.27K ﹤0.01% 933
2014
Q4 		$17K Buy
11,524
+17
+0.1% +$25 ﹤0.01% 856
2014
Q3 		$24K Sell
11,507
-9
-0.1% -$19 ﹤0.01% 836
2014
Q2 		$35K Sell
11,516
-451
-4% -$1.37K 0.01% 864
2014
Q1 		$30K Buy
11,967
+1,336
+13% +$3.35K 0.01% 829
2013
Q4 		$53K Buy
+10,631
New +$53K 0.01% 819

Amalgamated Bank's RXII Position: Q4 2016 in Review

Amalgamated Bank sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 19,454 shares — an estimated $7K sold.

Amalgamated Bank first reported a position in RXII in Q4 2013 and held it in 12 quarters. The position peaked at $53K in Q4 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Amalgamated Bank reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Amalgamated Bank sold 19,454 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $7K.
  • Amalgamated Bank first reported a position in GALENA BIOPHARMA INC COM in Q4 2013 and held it in 12 quarters.
  • Amalgamated Bank's GALENA BIOPHARMA INC COM position peaked at $53K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Amalgamated Bank's 13F filing for Q4 2016, filed 14 Feb 2017.